|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| TOTAL CURRENT ASSETS | ||||||||||||||||||||
| Patents and trademarks, net of accumulated amortization of $330,179 and $291,255 | ||||||||||||||||||||
| OTHER ASSETS | ||||||||||||||||||||
| Patents and trademarks, net of accumulated amortization of $430,199 and $409,562 | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Embedded derivative liability | ||||||||||||||||||||
| Accounts payable and accrued expenses - related parties | ||||||||||||||||||||
| Loans payable | ||||||||||||||||||||
| 10% secured convertible notes payable - stockholders | ||||||||||||||||||||
| Secured convertible notes payable - stockholders | ||||||||||||||||||||
| 10% Secured Convertible Notes Payable | ||||||||||||||||||||
| 4% Secured Convertible Notes Payable | ||||||||||||||||||||
| 10% secured convertible notes payable - stockholders | ||||||||||||||||||||
| 10% Secured Convertible Notes Payable | ||||||||||||||||||||
| 4% Secured Convertible Notes Payable | ||||||||||||||||||||
| Notes payable - stockholders | ||||||||||||||||||||
| 4% secured convertible notes payable - stockholders | ||||||||||||||||||||
| 4% Secured Convertible Notes Payable | ||||||||||||||||||||
| Total 4% secured convertible notes payable - stockholders | ||||||||||||||||||||
| Notes payable - Other | ||||||||||||||||||||
| Preferred stock dividend liability | ||||||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||||||
| STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Common stock, $ .0001 par value; 230,000,000 shares authorized; 136,697,503 and 136,586,403 shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
Loading...